ClinicalTrials.Veeva

Menu

Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy (VO Qual)

U

University Hospital, Lille

Status

Completed

Conditions

Glottic Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT04447456
2020-A00738-31 (Other Identifier)
2019_68

Details and patient eligibility

About

Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outcome at 5 years of these two types of management in order to define whether one is superior to the other on this criterion of voice quality after treatment.

Enrollment

41 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with glottic squamous cell carcinoma T1N0M0 who may benefit from treatment with exclusive radiotherapy or exclusive surgery.
  • patients treated for these cancers at Lille University Hospital and the Oscar Lambret Centre between 2015 and 2017.
  • Tis, T1a and T1b glottic squamous cell carcinomas according to the TNM 7th edition classification in long-term survivors.

Exclusion criteria

Trial design

41 participants in 2 patient groups

Surgery
Radiotherapy

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems